Abstract
With the advancement of “proteomics” data and systems biology, new techniques are needed to meet the new era of drug discovery. Network theory is increasingly applied to describe complex biological systems, thus implying its essential roles in system-based drug design. In this review, we first summarized general network parameters used in describing biological systems, and then gave some recent applications of these network parameters as topological indices in drug design in terms of Protein Structure Networks (PSNs), Protein-Protein Interaction Networks (PPINs) including related structural PPINs, and Elastic Network Models (ENMs). These network models have enabled the development of new drugs relying on allosteric effects, describing anti-cancer targets, targeting hot spots and key proteins at the protein-protein interfaces and PPINs, and helped drug design by modulating conformational flexibility. Accordingly, we highlighted the integration of network models bringing new paradigms into the next-generation target-based drug discovery.
Keywords: Allosteric drugs, Biological networks, Drug targets, Hot spots, structural PPINs, Target flexibility.
Current Topics in Medicinal Chemistry
Title:Recent Advances on the Network Models in Target-based Drug Discovery
Volume: 18 Issue: 13
Author(s): Wenying Yan, Daqing Zhang, Chen Shen, Zhongjie Liang*Guang Hu*
Affiliation:
- Center for Systems Biology, Soochow University, Suzhou 215006,China
- Center for Systems Biology, Soochow University, Suzhou 215006,China
Keywords: Allosteric drugs, Biological networks, Drug targets, Hot spots, structural PPINs, Target flexibility.
Abstract: With the advancement of “proteomics” data and systems biology, new techniques are needed to meet the new era of drug discovery. Network theory is increasingly applied to describe complex biological systems, thus implying its essential roles in system-based drug design. In this review, we first summarized general network parameters used in describing biological systems, and then gave some recent applications of these network parameters as topological indices in drug design in terms of Protein Structure Networks (PSNs), Protein-Protein Interaction Networks (PPINs) including related structural PPINs, and Elastic Network Models (ENMs). These network models have enabled the development of new drugs relying on allosteric effects, describing anti-cancer targets, targeting hot spots and key proteins at the protein-protein interfaces and PPINs, and helped drug design by modulating conformational flexibility. Accordingly, we highlighted the integration of network models bringing new paradigms into the next-generation target-based drug discovery.
Export Options
About this article
Cite this article as:
Yan Wenying , Zhang Daqing , Shen Chen , Liang Zhongjie *, Hu Guang *, Recent Advances on the Network Models in Target-based Drug Discovery, Current Topics in Medicinal Chemistry 2018; 18 (13) . https://dx.doi.org/10.2174/1568026618666180719152258
DOI https://dx.doi.org/10.2174/1568026618666180719152258 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
Addressing the Most Common Causes of Death with Niacin/NAD and Inositol Polyphosphates
The most common causes of death in the world are cardiovascular disease (CVD) and cancer. These are perhaps best addressed by reducing lipodystrophy and blockages with niacin and inositol polyphosphates (e.g., IP6+inositol) respectively when addressing CVD. Niacin serves as a vitamin by virtue of its role as a skeletal precursor ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Microalbuminuria In Primary Hypertension
Current Hypertension Reviews Psychological Factors Associated with Response to Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Thresholds for Central Blood Pressures and Augmentation Indices - are They Needed and How Far are We in the Process of Their Definition?
Current Hypertension Reviews Cardiovascular Disease in Juvenile Idiopathic Arthritis
Current Vascular Pharmacology Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome
Current Pharmaceutical Design PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease
Current Pharmaceutical Design Epidemiology of Hypertension and Diabetes Mellitus in Latin America
Current Hypertension Reviews Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease
Current Pharmaceutical Design Immunological Facet and Inception after Post-COVID-19 Vaccination
Infectious Disorders - Drug Targets Regulation of Iron Absorption in Hemoglobinopathies
Current Molecular Medicine An Update on Parkinson’s Disease and its Neurodegenerative Counterparts
Current Medicinal Chemistry Approaches to Optimize Gene Therapy for the Treatment of Hematologic Malignancies: Overcoming the Obstacles
Current Gene Therapy Current Status in Iron Chelation in Hemoglobinopathies
Current Molecular Medicine Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening
Current Medicinal Chemistry Exercise for Adults with Fibromyalgia: An Umbrella Systematic Review with Synthesis of Best Evidence
Current Rheumatology Reviews Lifestyle Factors and Endothelial Function
Current Vascular Pharmacology Multifunctional Materials for Cancer Therapy: From Antitumoral Agents to Innovative Administration
Current Organic Chemistry Is BMI Associated with COVID-19 Severity? A Retrospective Observational Study
Current Medicinal Chemistry Concept of Comprehensive Treatment for Osteoarthritis (OA)
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study
Current Vascular Pharmacology